KA
MDLN

Kozak & Associates’s Medline Inc MDLN Stock Holding History

Kozak & Associates’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5K Hold
275
– – ﹤0.01% 255
2026
Q1 		$13K Buy
+275
New +$12.1K ﹤0.01% 241

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kozak & Associates's MDLN Position: Q2 2026 in Review

Kozak & Associates held its Medline Inc (MDLN) position steady in Q2 2026 at 275 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #255.

Kozak & Associates first reported a position in MDLN in Q1 2026 and has held it in 2 quarters since. The position peaked at $13K in Q1 2026. 231 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Kozak & Associates held 275 shares of Medline Inc worth $11.5K as of Q2 2026.
  • Kozak & Associates left its Medline Inc share count unchanged in Q2 2026.
  • Medline Inc made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #255 holding.
  • Kozak & Associates first reported a position in Medline Inc in Q1 2026 and has held it in 2 quarters since.
  • Kozak & Associates's Medline Inc position peaked at $13K in Q1 2026.
  • 231 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.